Novel Methods to Reduce Children's Secondhand Smoke Exposure II (EZII)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- The Children's Hospital at OU Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
In order to be included in the study, participants must:
- be the primary caregiver(defined as a person who spends the most time with the child and spends a minimum of 4 hours per day in the presence of the child) of a child between the ages of 3-11 (if caregiver has more > 1 child between 3-11 years, we will include the youngest),
- smoke at least 10 cigarettes per day for the past year,
- indicate that they smoke around their child or in the car or home at least one time per week],
- have no intention of quitting smoking in the next 12-weeks,
- aged 18-65 years,
- be fluent in English,
- have no recent history of cardiovascular distress that may contraindicate medicinal nicotine lozenge use (heart attack in the past year, arrhythmia, uncontrolled hypertension),
- not currently pregnant, planning to become pregnant, or breastfeeding,
- do not use non-cigarette tobacco (cigars, chewing tobacco)
- have no prior use of any potential reduced exposure product,
- have no major psychiatric impairment, including psychosis, suicidality, and/or any current alcohol/drug abuse or dependence
Exclusion Criteria:
Does not meet all of the requirements of inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Counseling
|
|
|
Experimental: Nicotine lozenge
Participants will receive nicotine lozenge to use as needed for 12 weeks.
|
|
|
Experimental: Tobacco lozenge
Participants will receive tobacco lozenge to use as needed for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Child Salivary Cotinine
Time Frame: 3, 6, and 12 weeks
|
Child salivary cotinine will be measured to assess the level of secondhand smoke exposure.
We will measure the change throughout the study.
|
3, 6, and 12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Parent and Child Lung Function
Time Frame: 3, 6, 12 weeks
|
We will collect both parent and child spirometry data and compare changes.
|
3, 6, 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Theodore Wagener, Ph.D., OTRC, OU Children's Hospital Dept. of Pediatrics, OU Cancer Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 0642P
- 1R21CA164521-01A1 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.